Defense Stock Dragged Lower By Tariff Headwinds
Defense stock Axon Enterprise Inc (NASDAQ:AXON) is plummeting today, down 14.1% at $606.37 at last glance.
TASER maker Axon plunges 17% after earnings fall short due to tariff hit
Axon Enterprise's stock plummeted after the TASER maker missed Wall Street's third-quarter profit expectations due to tariff constraints. The company said its connected devices business, which includes TASERS and counter drone equipment, felt the biggest pinch from the first full tariff quarter.
Axon Enterprise, Inc. (AXON) Q3 2025 Earnings Call Transcript
Axon Enterprise, Inc. ( AXON ) Q3 2025 Earnings Call November 4, 2025 5:00 PM EST Company Participants Patrick Smith - Founder, CEO & Director Joshua Isner - President Brittany Bagley - COO & CFO Conference Call Participants George Notter - Wolfe Research, LLC Jeremy Hamblin - Craig-Hallum Capital Group LLC, Research Division Andrew Sherman - TD Cowen, Research Division James Fish - Piper Sandler & Co., Research Division Ioannis Samoilis - Robert W. Baird & Co. Incorporated, Research Division Trevor Walsh - Citizens JMP Securities, LLC, Research Division Andrew Spinola - UBS Investment Bank, Research Division Jordan Lyonnais - BofA Securities, Research Division Joshua Reilly - Needham & Company, LLC, Research Division Presentation Operator Hi, everyone, and thank you for joining Axon's executive team today.
Compared to Estimates, Axon (AXON) Q3 Earnings: A Look at Key Metrics
The headline numbers for Axon (AXON) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Axon Enterprise (AXON) Lags Q3 Earnings Estimates
Axon Enterprise (AXON) came out with quarterly earnings of $1.17 per share, missing the Zacks Consensus Estimate of $1.63 per share. This compares to earnings of $1.45 per share a year ago.
Axon Enterpise: AI Era And Large Firms To Drive Growth Upside Into 2026
Axon Enterprise (AXON) continues strong growth, supported by a large backlog and expanding beyond state and local government deployments. AXON is launching the Axon Body Workforce Mini, a lightweight body camera targeting retail and hospital employees, with rollout expected in mid-2026. The new camera offers features like instant translation and a panic button, with evidence.com data storage providing high-margin recurring revenue from enterprises starting in 2026.
Axon Enterprise (AXON) Falls More Steeply Than Broader Market: What Investors Need to Know
Axon Enterprise (AXON) concluded the recent trading session at $738.88, signifying a -2.71% move from its prior day's close.
Countdown to Axon (AXON) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Axon (AXON), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.
Here is What to Know Beyond Why Axon Enterprise, Inc (AXON) is a Trending Stock
Axon (AXON) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
AXON Enhances its Counter-Drone Presence With TYTAN Partnership
Axon deepens its counter-drone presence as Dedrone's AI-driven platform and new TYTAN partnership boost its CUAS capabilities.
Axon Enterprise (AXON) Exceeds Market Returns: Some Facts to Consider
Axon Enterprise (AXON) concluded the recent trading session at $727.41, signifying a +1.79% move from its prior day's close.
Axon: Buy On Innovative Growth And Strong Bookings
Axon Enterprise remains a Buy due to robust growth, innovative products, and strong revenue guidance despite a volatile share price and high valuation. AXON's new ABW Mini camera targets retail and healthcare, addressing workplace safety and expanding potential revenue streams starting in 2026. Recurring revenue, bookings, and net revenue retention rates are at record highs, supporting long-term growth and financial stability for AXON.
